Abbott SK; Jenner AM; Spiro AS; Batterham M; Halliday GM; Garner B, 2015, 'Fatty acid composition of the anterior cingulate cortex indicates a high susceptibility to lipid peroxidation in Parkinson's disease', Journal of Parkinson's Disease, vol. 5, pp. 175 - 185, http://dx.doi.org/10.3233/JPD-140479

Li H; Ruberu K; Muñoz SS; Jenner AM; Spiro A; Zhao H; Rassart E; Sanchez D; Ganfornina MD; Karl T; Garner B, 2015, 'Apolipoprotein D modulates amyloid pathology in APP/PS1 Alzheimer's disease mice', Neurobiology of Aging, vol. 36, pp. 1820 - 1833, http://dx.doi.org/10.1016/j.neurobiolaging.2015.02.010

Cheng D; Low JK; Logge W; Garner B; Karl T, 2014, 'Novel behavioural characteristics of female APPSwe/PS1δE9 double transgenic mice', Behavioural Brain Research, vol. 260, pp. 111 - 118, http://dx.doi.org/10.1016/j.bbr.2013.11.046

Cheng D; Low JK; Logge W, 2014, 'Research Article', Psychopharmacology (Berl), vol. 231, pp. 3009 - 3017, http://dx.doi.org/10.1007/s00213-014-3478-5

Couttas TA; Kain N; Daniels B; Lim XY; Shepherd C; Kril J; Pickford R; Li H; Garner B; Don AS, 2014, 'Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease pathogenesis', Acta Neuropathologica Communications, vol. 2, http://dx.doi.org/10.1186/2051-5960-2-9

Murphy KE; Gysbers AM; Abbott SK; Tayebi N; Kim WS; Sidransky E; Cooper A; Garner B; Halliday GM, 2014, 'Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease', Brain, vol. 137, pp. 834 - 848, http://dx.doi.org/10.1093/brain/awt367

Abbott SK; Li H; Muñoz SS; Knoch B; Batterham M; Murphy KE; Halliday GM; Garner B, 2014, 'Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease', Movement Disorders, vol. 29, pp. 518 - 526, http://dx.doi.org/10.1002/mds.25729

Cheng D; Spiro AS; Jenner AM; Garner B; Karl T, 2014, 'Long-term cannabidiol treatment prevents the development of social recognition memory deficits in alzheimer's disease transgenic mice', Journal of Alzheimer's Disease, vol. 42, pp. 1383 - 1396, http://dx.doi.org/10.3233/JAD-140921

Bhatia S; Jenner AM; Li H; Ruberu K; Spiro AS; Shepherd CE; Kril JJ; Kain N; Don A; Garner B, 2013, 'Increased apolipoprotein D dimer formation in alzheimer's disease hippocampus is associated with lipid conjugated diene levels', Journal of Alzheimer's Disease, vol. 35, pp. 475 - 486, http://dx.doi.org/10.3233/JAD-122278

Kim WS; Li H; Ruberu K; Chan S; Low JK; Low JK; Cheng D; Karl T; Garner B; Elliott D, 2013, 'Deletion of Abca7 increases cerebral amyloid-â accumulation in the J20 mouse model of Alzheimer's disease', Journal of Neuroscience, vol. 33, pp. 4387 - 4394, http://dx.doi.org/10.1523/JNEUROSCI.4165-12.2013

Cheng D; Logge W; Low JK; Garner B; Karl T, 2013, 'Novel behavioural characteristics of the APPSwe/PS1ΔE9 transgenic mouse model of Alzheimer's disease', Behavioural Brain Research, vol. 245, pp. 120 - 127, http://dx.doi.org/10.1016/j.bbr.2013.02.008

Abbott SK; Jenner AM; Mitchell T; Brown S; Halliday GM; Garner B, 2013, 'An Improved High-Throughput lipid extraction method for the analysis of human brain lipids', Lipids, vol. 48, pp. 307 - 318, http://dx.doi.org/10.1007/s11745-013-3760-z

Logge W; Cheng DK; Chesworth R; Bhatia S; Garner B; Kim WS; Karl T, 2012, 'Role of Abca7 in Mouse Behaviours Relevant to Neurodegenerative Diseases', PLoS ONE, vol. 7, pp. Article numbere45959, http://dx.doi.org/10.1371/journal.pone.0045959

Karl T; Bhatia S; Cheng D; Kim WS; Garner B, 2012, 'Cognitive phenotyping of amyloid precursor protein transgenic J20 mice', Behavioural Brain Research, vol. 228, pp. 392 - 397, http://dx.doi.org/10.1016/j.bbr.2011.12.021

Wong JCY; Garner B; Halliday GM; Kwok JBJ, 2012, 'Srp20 regulates TrkB pre-mRNA splicing to generate TrkB-Shc transcripts with implications for Alzheimer's disease', Journal of Neurochemistry, vol. 123, pp. 159 - 171, http://dx.doi.org/10.1111/j.1471-4159.2012.07873.x

Karl T; Cheng D; Garner B; Arnold JC, 2012, 'The therapeutic potential of the endocannabinoid system for Alzheimer's disease', Expert Opinion on Therapeutic Targets, vol. 16, pp. 407 - 419, http://dx.doi.org/10.1517/14728222.2012.671812

Cheng D; Jenner AM; Shui G; Cheong WF; Mitchell T; Nealon J; Kim WS; McCann H; Wenk M; Halliday ; Garner B, 2011, 'Lipid pathway alterations in parkinson's disease primary visual cortex', PLoS One, vol. 6, pp. e17299, http://dx.doi.org/10.1371/journal.pone.0017299

Kim WS; Hill A; Fitzgerald M; Freeman MW; Evin G; Garner B, 2011, 'Wild type and Tangier disease ABCA1 mutants modulate cellular amyloid-beta production independent of cholesterol efflux activity', Journal of Alzheimer's Disease, vol. 27, pp. 441 - 452, http://dx.doi.org/10.3233/JAD-2011-110521

Kagedal K; Kim WS; Appelqvist A; Chan LL; Cheng D; Agholme L; Barnham K; Mccann H; Halliday GM; Garner B, 2010, 'Increased expression of the lysosomal cholesterol transporter NPC1 in Alzheimer's disease', Biochimica et Biophysica ACTA - Molecular and Cell Biology of Lipids, vol. 1801, pp. 831 - 838, http://dx.doi.org/10.1016/j.bbalip.2010.05.005

Li H; Kim WS; Guillemin GJ; Hill AF; Evin G; Garner B, 2010, 'Modulation of amyloid precursor protein processing by synthetic ceramide analogues', Biochimica et Biophysica ACTA - Molecular and Cell Biology of Lipids, vol. 1801, pp. 887 - 895, http://dx.doi.org/10.1016/j.bbalip.2010.05.012

Chen Y; Stankovic R; Cullen KM; Meininger V; Garner B; Coggan SE; Grant RS; Brew BJ; Guillemin GJ, 2010, 'The Kynurenine Pathway and Inflammation in Amyotrohic Lateral Sclerosis', Neurotoxicity Research, vol. 18, pp. 132 - 142, http://dx.doi.org/10.1007/s12640-009-9129-7

Piguet O; Garner B, 2010, 'Vascular pharmacotherapy and dementia', Current Vascular Pharmacology, vol. 8, pp. 44 - 50, http://dx.doi.org/10.2174/157016110790226705

Glaros E; Kim WS; Garner B, 2010, 'Myriocin-mediated up-regulation of hepatocyte apoA-I synthesis is associated with ERK inhibition', Clinical Science, vol. 118, pp. 727 - 736, http://dx.doi.org/10.1042/CS20090452

Kim WS; Bhatia S; Elliott DA; Agholme L; Kagedal K; Mccann H; Halliday GM; Barnham K; Garner B, 2010, 'Increased ATP-binding cassette trabsporter A1 expression in Alzheimer's disease hippocampal neurons', Journal of Alzheimer's Disease, vol. 21, pp. 193 - 205, http://dx.doi.org/10.3233/JAD-2010-100324

Scott Kim W; Chan SL; Hill AF; Guillemin GJ; Garner B, 2009, 'Impact of 27-hydroxycholesterol on amyloid-β peptide production and ATP-binding cassette transporter expression in primary human neurons', Journal of Alzheimer's Disease, vol. 16, pp. 121 - 131, http://dx.doi.org/10.3233/JAD-2009-0944

Kim WS; Chan LL; Hill AF; Guillemin GJ; Garner B, 2009, 'Impact of 27-hydroxycholesterol on amyloid-beta peptide production and ATP-binding cassette transporter expression in primary human neurons', Journal of Alzheimer's Disease, vol. 16, pp. 121 - 131, http://dx.doi.org/10.3233/JAD-2009-0944

Kim WS; Wong J; Shannon-Weickert C; Webster MJ; Bahn S; Garner B, 2009, 'Apolipoprotein-D expression is increased during development and maturation of the human prefrontal cortex', Journal of Neurochemistry, vol. Volume 109, pp. 1053 - 1066, http://dx.doi.org/10.1111/j.1471-4159.2009.06031.x

Chan LL; Kim WS; Kwok JB; Hill AF; Cappai R; Rye K; Garner B, 2008, 'ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro', Journal of Neurochemistry, vol. 106, pp. 793 - 804, http://dx.doi.org/10.1111/j.1471-4159.2008.05433.x

Cheng D; Kim WS; Garner B, 2008, 'Regulation of alpha-synuclein expression by liver X receptor ligands in vitro', Neuroreport, vol. 19, pp. 1685 - 1689, http://dx.doi.org/10.1097/WNR.0b013e32831578b2

Glaros EN; Kim WS; Rye K; Shayman J; Garner B, 2008, 'Reduction of plasma glycosphingolipid levels has no impact on atherosclerosis in apolipoprotein E-null mice', Journal of Lipid Research, vol. 49, pp. 1677 - 1681, http://dx.doi.org/10.1194/jlr.E800005-JLR200

Double KL; Dedov V; Fedorow HS; Kettle E; Halliday GM; Garner B; Brunk U, 2008, 'The comparative biology of neuromelanin and lipofuscin in the human brain', CMLS - Cellular and Molecular Life Sciences, vol. 65, pp. 1669 - 1682, http://dx.doi.org/10.1007/s00018-008-7581-9

Glaros EN; Kim WS; Quinn CM; Jessup W; Rye K; Garner B, 2008, 'Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mice', Journal of Lipid Research, vol. 49, pp. 324 - 331, http://dx.doi.org/10.1194/jlr.M700261-JLR200

Kim WS; Elliott DA; Kockx M; Kritharides L; Rye K; Jans D; Garner B, 2008, 'Analysis of apolipoprotein E nuclear localization using green fluorescent protein and biotinylation approaches', Biochemical Journal, vol. 409, pp. 701 - 709, http://dx.doi.org/10.1042/BJ20071261

Garner B, 2008, 'Myriocin as an atherosclerosis inhibitor', Future Lipidology, vol. 3, pp. 221 - 224, http://dx.doi.org/10.2217/17460875.3.3.221

Nasrallah F; Garner B; Ball GE; Rae CD, 2008, 'Modulation of brain metabolism by very low concentrations of the commonly used drug delivery vehicle dimethyl sulfoxide (DMSO)', Journal of Neuroscience Research, vol. 86, pp. 208 - 214, http://dx.doi.org/10.1002/jnr.21477

Kim WS; Shannon-Weickert C; Garner B, 2008, 'Role of ATP-binding cassette transporters in brain lipid transport and neurological disease', Journal of Neurochemistry, vol. 104, pp. 1145 - 1166, http://dx.doi.org/10.1111/j.1471-4159.2007.05099

Elliott DA; Kim WS; Jans D; Garner B, 2008, 'Macrophage apolipoprotein-E knockdown modulates caspase-3 activation without altering sensitivity to apoptosis', Biochimica et Biophysica ACTA - General Subjects, vol. 1780, pp. 145 - 153, http://dx.doi.org/10.1016/j.bbagen.2007.10.021

Kim WS; Suryo A; Kamili A; Rye K; Guillemin GJ; Gelissen I; Jessup W; Hill A; Garner B, 2007, 'Novel functions for ABCG1 in the regulation of cholesterol efflux to apoE discs and neuronal generation of amyloid-beta peptide', The Journal of Biological Chemistry, vol. 282, pp. 2851 - 2861

Guillemin GJ; Cullen K; Smythe GA; Kapoor V; Lim E; Garner B; Takikawa O; Brew BJ, 2007, 'Characterization of the kynurenine pathway in human neurons', Journal of the History of the Neurosciences, vol. 27, pp. 12884 - 12892

Glaros EN; Kim WS; Wu BJ; Suarna C; Quinn CM; Rye K; Stocker R; Jessup W; Garner B, 2007, 'Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration', Biochemical Pharmacology, vol. 73, pp. 1340 - 1346, http://dx.doi.org/10.1016/j.bcp.2006.12.023

Dedov V; Griffiths F; Garner B; Halliday GM; Double KL, 2007, 'Lipid content determines aggregation of neuromelanin granules in vivo', Journal of Neural Transmission - Supplement, vol. 72, pp. 35 - 38, http://dx.doi.org/10.1007/978-3-211-73574-9-5

Guillemin GJ; Cullen K; Lim C; Smythe GA; Garner B; Kapoor V; Takikawa O; Brew BJ, 2007, 'Characterization of the kynurenine pathway in human neurons', Journal of Neuroscience, vol. 27, pp. 12884 - 12892, http://dx.doi.org/10.1523/JNEUROSCI.4101-07.2007

Kim WS; Rahmanto A; Kamili A; Rye K; Guillemin GJ; Gelissen I; Jessup W; Hill A; Garner B, 2007, 'Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation', The Journal of Biological Chemistry, vol. 282, pp. 2851 - 2861, http://dx.doi.org/10.1074/jbc.M607831200

Broeer S; Broeer A; Hansen J; Bubb W; Balcar VJ; Nasrallah F; Garner B; Rae CD, 2007, 'Alanine metabolism, transport, and cycling in the brain', Journal of Neurochemistry, vol. 102, pp. 1758 - 1770, http://dx.doi.org/10.1111/j.1471-4159.2007.04654.x

Elliott DA; Kim WS; Jans D; Garner B, 2007, 'Apoptosis induces neuronal apolipoprotein-E synthesis and localization in apoptotic bodies', Neuroscience Letters, vol. 416, pp. 206 - 210, http://dx.doi.org/10.1016/j.neulet.2007.02.014

Kim WS; Guillemin GJ; Glaros EN; Lim CK; Garner B, 2006, 'Quantitation of ABCA transporter gene expression in primary human brain cells', Neuroreport, vol. 17, pp. 891 - 896

Fedorow HS; Pickford R; Kettle E; Cartwright M; Halliday GM; Gerlach M; Riederer P; Garner B; Double KL, 2006, 'Investigation of the lipid component of neuromelanin', Journal of Neural Transmission, vol. 113, pp. 735 - 739, http://dx.doi.org/10.1007/s00702-006-0451-4

Kim WS; Guillemin GJ; Glaros EN; Garner B, 2006, 'Quantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cells', Neuroreport, vol. 17, pp. 891 - 896, http://dx.doi.org/10.1097/01.wnr.0000221833.41340.cd

He Z; Aristoteli LP; Kritharides L; Garner B, 2006, 'HPLC analysis of discrete haptoglobin isoform N-linked oligosaccharides following 2D-PAGE isolation', Biochemical and Biophysical Research Communications, vol. 343, pp. 496 - 503, http://dx.doi.org/10.1016/j.bbrc.2006.03.007

Kim WS; Chalfant CE; Garner B, 2006, 'Fine tuning therapeutic targeting of the sphingolipid biosynthetic pathway to treat atherosclerosis', Current Vascular Pharmacology, vol. 4, pp. 151 - 154, http://dx.doi.org/10.2174/157016106776359844

Fedorow HS; Pickford R; Hook JM; Double KL; Halliday GM; Gerlach M; Riederer P; Garner B, 2005, 'Dolichol is the major lipid component of human substantia nigra neuromelanin', Journal of Neurochemistry, vol. 92, pp. 990 - 995, http://dx.doi.org/10.1111/j.1471-4159.2004.02975.x

Raftery MJ; Campbell R; Glaros EN; Rye K; Halliday GM; Jessup W; Garner B, 2005, 'Phosphorylation of apolipoprotein-E at an atypical protein kinase CK2 PSD/E site in vitro.', Biochemistry, vol. 44, pp. 7346 - 7353, http://dx.doi.org/10.1021/bi0504052

Glaros EN; Kim WS; Quinn CM; Wong J; Gelissen I; Jessup W; Garner B, 2005, 'Glycosphingolipid accumulation inhibits cholesterol efflux via the ABCA1/apolipoprotein A-I pathway 1-Phenyl-2-decanoylamino-3-morpholino-1-propanol is a novel cholesterol efflux accelerator', The Journal of Biological Chemistry, vol. 280, pp. 24515 - 24523, http://dx.doi.org/10.1074/jbc.M413862200

Quinn CM; Kagedal K; Terman A; Stroikin U; Brunk U; Jessup W; Garner B, 2004, 'Induction of fibroblast apolipoprotein E expression during apoptosis, starvation-induced growth arrest and mitosis', Biochemical Journal, vol. 378, pp. 753 - 761

Tedla NT; Glaros EN; Brunk U; Jessup W; Garner B, 2004, 'Heterogeneous expression of apolipoprotein-E by human macrophages', Immunology, vol. 113, pp. 338 - 347, http://dx.doi.org/10.1111/j.1365-2567.2004.01972.x

Quinn CM; Kagedal K; Terman A; Stroikin U; Brunk U; Jessup W; Garner B, 2003, 'Induction of fibroblast apolipoprotein-E expression during apoptosis, starvation-induced growth arrest and mitosis', Biochemical Journal, vol. On-line, pp. 753 - 761, http://dx.doi.org/10.1042/BJ20031352

Kim WS; Hill AF; Garner B, 2008, '27-hydroxycholesterol regulates amyloid-beta peptide production via ABC transporters', in Proceedings of Aust Neuroscience Society, Australian Neuroscience Society 28th Annual Meeting, Hobart, pp. 38 - 38, presented at Australian Neuroscience Society 28th Annual Meeting, Hobart, 27 January 2008 - 30 January 2008

Guillemin GJ; Cullen KM; Smythe GA; Lim CK; Garner B; Brew BJ, 2008, 'Characterization of the kynurenine pathway in human primary neurons', in Proceedings of Aust Neuroscience Society, Australian Neuroscience Society 28th Annual Meeting, Hobart, pp. 78 - 78, presented at Australian Neuroscience Society 28th Annual Meeting, Hobart, 27 January 2008 - 30 January 2008

Elliott DA; Kim WS; Garner B, 2008, 'Post-translational modifications of apolipoprotein-E in the human brain', in Proceedings of Aust Neuroscience Society, Australian Neuroscience Society 28th Annual Meeting, Hobart, pp. 112 - 112, presented at Australian Neuroscience Society 28th Annual Meeting, Hobart, 27 January 2008 - 30 January 2008

Cheng D; Kim WS; Garner B, 2008, 'Potential regulation of human alpha-synuclein gene expression by liver X receptor alpha', in Proceedings of Aust Neuroscience Society, Australian Neuroscience Society 28th Annual Meeting, Hobart, pp. 114 - 114, presented at Australian Neuroscience Society 28th Annual Meeting, Hobart, 27 January 2008 - 30 January 2008

Fedorow HS; Pickford R; Hook J; Double KL; Halliday GM; Gerlach M; Riederer P; Garner B, 2005, 'Dolichol is the major lipid component of neuromelanin in human substanta nigra', in Parkinsonism and Related Disorders, Elsevier Sci Ltd, Kidlington, Oxford, England, pp. 107 - 107, presented at 16th International Congress on Parkinson`s Disease and Related Disorders, Berlin, Germany, 05 June 2005 - 09 June 2005

Fedorow HS; Garner B; Pickford R; Hook JM; Kettle E; Cartwright HR; Double KL; Gerlach M; Riederer P; Halliday GM, 2005, 'Investigations of the lipid component of neuromelanin', in Parkinsonism and Related Disorders, Elsevier Sci Ltd, Kidlington, Oxford, England, pp. 58 - 58, presented at 16th International Congress on Parkinson`s Disease and Related Disorders, Berlin, Germany, 05 June 2005 - 09 June 2005

Fedorow HS; Pickford R; Hook JM; Double KL; Halliday GM; Gerlach M; Riederer P; Garner B, 2005, 'Identification of the major lipid component of neuromelanin in human dopamine neurons', in Proceedings of Aust Neuroscience Society, 25th Annual Meeting of the Australian Neuroscience Society, Perth, WA, pp. 139 - 139, presented at 25th Annual Meeting of the Australian Neuroscience Society, Perth, WA, 30 January 2005 - 02 February 2005